• 한국미생물·생명공학회지
• /
• 제31권2호
• /
• pp.129-134
• /
• 2003

본 실험의 목적은 Gram 양성균 뿐만 아니라 어병세균인 Gram 음성세균에 대한 넓은 항균활성 및 내산성 그리고 항생제 내성을 갖고 있는 유용한 probiotic 후보균주를 선발하여 어류의 세균성 질병 예방 혹은 치료를 함으로써 양식산업의 효율성을 증대시키고자 한다. 20종의 유산균을 김치, 양식 넙치의 장 그리고 각종 젓갈류 등에서 분리하여 어류병원성 세균에 대한 항균능을 MRS agar상에서 agar spotted method에 의해 조사하여 Vibrio anguillarum, Edwardsiella tarda, 그리고 Streptococcus sp.에 대해 항균활성이 있는 7종의 균주를 1차 선발을 하였다. pH 및 항생제 내성능을 검토하여 probiotic 균주를 분리하였다. 분리된 후보 균중 창란젓에서 분리된 BK19에서 가장 큰 항균 spectrum과 pH 내성 그리고 항생제에 대한 내성이 확인되어 최종적으로 본 실험의 공시균주로 선발하여 생화학적, 형태학적 특성 및 16S rRNA 분석을 통하여 Lactobacillus sakei BK19로 동정하였다.

• 한국축산식품학회지
• /
• 제43권4호
• /
• pp.659-673
• /
• 2023

Compared to infant formula, breast milk is the best source of nutrition for infants; it not only improves the neonatal intestinal function, but also regulates the immune system and gut microbiota composition. However, probiotic-fortified infant formula may further enhance the infant gut environment by overcoming the limitations of traditional infant formula. We investigated the probiotic formula administration for one month by comparing 118 Korean infants into the following three groups: infants in each group fed with breast milk (50), probiotic formula (35), or placebo formula-fed group (33). Probiotic formula improved stool consistency and defecation frequency compared to placebo formula-fed group. The probiotic formula helped maintaining the level of secretory immunoglobulin A (sIgA), which had remarkably decreased over time in placebo formula-fed infants (compared to weeks 0 and 4). Moreover, probiotic formula decreased the acidity of stool and considerably increased the butyrate concentration. Furthermore, the fecal microbiota of each group was evaluated at weeks 0 and 4. The microbial composition was distinct between each groups, and the abundance of health-promoting bacteria increased in the probiotic formula compared to the placebo formula-fed group. In summary, supplementation of probiotic infant formula can help optimize the infant gut environment, microbial composition, and metabolic activity of the microbiota, mimicking those of breast milk.

• 식품기술
• /
• 제15권1호
• /
• pp.55-61
• /
• 2002

장내 균총 개선을 위하여 조합시킨 prebiotics와 probiotics는 최고의 건강 증진을 제공할 잠재성을 갖지만, 알맞은 균주선발이 필수적이다. 기능성 식품시장은 연간 15∼20% 성장하고 있고, 그 산업은 33백만 달러의 값어치가 있다(Hilliam, 2000). 기능성 식품은 nutraceuticals, designer foods, medicinal foods, therapeutic foods,superfoods, foodiceuticals와 medifoods로 알려져 있고 그 정의는 전통적인 영양소개념을 넘어선 건강증진 성분을 함유한 식품이라고 할 수 있다(Berner와 O'Donnell,1998). 식품은 phytochemicals, bioactive peptides, $\omega$-3 불포화 지방산, 그리고probiotics 또는 기능성을 갖게 되는 prebiotics의 부가에 의하여 변형될 수 있다(Berner와 O'Donnell, 1998)(표 1). 장관에서 살수 없는 균을 함유한 요구르트의 경우와 같은 다양한 발효 낙농식품 제조에 젖산균을 사용한 이래, 오늘날에는 발효식품에Lactobacillus acidophilus와 bifidobacteria 같은 probiotic 균을 사용하는 경향이다. Probiotic 식품은 살아 있는 미생물을 함유한 식품이고, 그 미생물은 충분한 양이살아 있는 상태로 장 속에 공급되었을 때에 미생물 균총을 개선하여 소비자 건강을 증진시키는 것이라고 할 수 있다(Fuller, 1992). 전통적으로, probiotics는 요구르트와 기타 발효식품에 사용되어 왔지만, 최근에는 드링크, 알약형, 캡슐형, 동결건조물과 같은 형태로도 공급되고 있다. 오늘날, 전세계에 sour cream, buttermilk, 요구르트, 분유와 frozen desserts 같은 식품에 bifidus acidophilus를 함유한 제품이 70개를 넘고 있으며, 일본에서만도 probiotic 미생물을 함유한 형태의 우유제품이 53종류 이상 개발되어 있다. Probiotics는 유럽에서도 매우 인기가 있지만, 주로 요구르트에 한정되어 사용되고 있다(Hilliam, 2000).

• 한국축산식품학회지
• /
• 제30권1호
• /
• pp.1-12
• /
• 2010

The immune system is generally divided into the innate and the adopted immune systems, both protecting the body from pathogens. Recently, allergies, a disease associated with an imbalanced immune system, have increased rapidly in developed countries. Prevailing symptoms of allergic diseases are eczema, allergic rhinitis, asthma, inflammatory bowel disease, and food allergy. Probiotic bacteria, mainly consisting of lactic acid bacteria, are used in the prevention and treatment of allergic diseases. The function of them is to stimulate the intestinal immune cells and form a complex signal network to activate other immune cells. Beneficial health effects of probiotics are based on the hygiene hypothesis, which suggests that sanitary environment is important for health, but limited exposure to environmental factors increases allergic diseases. An immunoregulatory effect of probiotic bacteria is demonstrated by controlled trial, animal model, in vitro, in vivo and ex vivo designs. However, the immunoregulatory effect of probiotic bacteria is controversial because it depends on probiotic strains, a dose and a type of diseases. In this review, we discussed clinical evidences on immunoregulatory effects of probiotic bacteria.

• Journal of Dairy Science and Biotechnology
• /
• 제34권4호
• /
• pp.203-216
• /
• 2016

지난 수십 년 동안 행복과 건강에 있어서 식품의 긍정적인 역할에 대한 소비자들의 관심과 인식의 증가 등의 이유로 기능성 식품의 생산 방향으로 식품산업이 변화되어가고 있다. Probiotic 식품의 정의에 의하면, 소비자들의 건강에 도움을 줄 수 있는 충분한 양의 살아있는 미생물을 반드시 포함해야 된다고 규정하고 있다. 오늘날 많은 probiotic 식품들이 판매되고 있으며, 또한 다양한 probiotic 균주들은 상업적으로 이용되고 있다. 하지만, 미생물들의 실제적으로 잠재적인 능력을 어떻게 평가하는 것은 매우 관심을 가지는 부분이다. 왜냐하면 최근 관련 문헌의 검사에서도 알 수 있듯이, probiotic 관련 연구가 급속하게 증가하고 있기에 더욱더 이 부분은 중요하게 인식되어지고 있다. 비록 대부분의 probiotic 미생물들은 식품 또는 공생세균으로서 일반적으로 안전하다고 여겨지고 있지만, 그 외의 재료들에서 얻은 probiotics는 법적인 규제와 안전문제에 대한 우려가 더욱더 증가되고 있는 것은 사실이다. Probiotic으로서 잠재력을 가진 균주들은 in vitro 또는 in vivo 검사를 통해서 선별되어질 수 있다. 예를 들면, 위장 또는 담즙과 같은 산성의 조건에서도 생존능력은 간단한 실험을 통해서 평가될 수 있으며, 또는 면역 활성, 신진대사 기능 또는 장-뇌 상호작용과 같은 복잡한 숙주 기능에서도 영향력의 평가가 가능하게 이루어질 수 있다. 인간의 건강 증진을 위해서는 반드시 고려되어야 하는 것은 궁극적으로 인간을 대상으로 진행되는 임상시험이지만, 지금까지 긍정적인 결과를 나타내는 연구를 통해서 밝혀진 소수의 균주들만이 법적으로 건강 기능성 강조표시(health claim)를 획득할 수 있었다. 따라서 현재 probiotics라고 규정하는데 이용되는 검사방법들의 유효성에 대한 관심이 증가하고 있는 것이 사실이다. 따라서 본 총설논문에서 probiotics의 선별에 이용되는 가장 일반적인 방법과 이들 방법들의 장점 및 한계성에 관해서 자세하게 설명하였다. 더 나아가서, 최근에 omics 기술의 출현은 probiotics의 생물현상을 새롭게 이해하는데 큰 도움으로 주고 있으며, 결국 omics 기술은 probiotics와 같은 다양한 미생물들을 연구하고 선별하는데 새로운 방법으로 이용될 수 있을 것이다. 하지만 여기에 대한 추가적인 연구들은 반드시 진행되어야 할 것이다.

• 한국축산식품학회지
• /
• 제41권6호
• /
• pp.967-982
• /
• 2021

Probiotics are living microorganisms that, when administered in adequate amounts, provide a health benefit to the host and are considered safe. Most probiotic strains that are beneficial to human health are included in the "Lactic acid bacteria" (LAB) group. The positive effects of probiotic bacteria on the host's health are species-specific and even strain-specific. Therefore, evaluating the probiotic potential of both wild and novel strains is essential. In this study, the probiotic characteristics of Lactobacillus brevis KT38-3 were determined. The strain identification was achieved by 16S rRNA sequencing. API-ZYM test kits were used to determine the enzymatic capacity of the strain. L. brevis KT38-3 was able to survive in conditions with a broad pH range (pH 2-7), range of bile salts (0.3%-1%) and conditions that simulated gastric juice and intestinal juice. The percentage of autoaggregation (59.4%), coaggregation with E. coli O157:H7 (37.4%) and hydrophobicity were determined to be 51.1%, 47.4%, and 52.7%, respectively. L. brevis KT38-3 produced β-galactosidase enzymes and was able ferment lactose. In addition, this strain was capable of producing antimicrobial peptides against the bacteria tested, including methicillin and/or vancomycin-resistant bacteria. The cell-free supernatants of the strain had high antioxidant activities (DPPH: 54.9% and ABTS: 48.7%). Therefore, considering these many essential in vitro probiotic properties, L. brevis KT38-3 has the potential to be used as a probiotic supplement. Supporting these findings with in vivo experiments to evaluate the potential health benefits will be the subject of our future work.

• Asian-Australasian Journal of Animal Sciences
• /
• 제22권1호
• /
• pp.119-123
• /
• 2009

In vitro acid- and bile-tolerant lactic acid bacteria isolated and identified from Indonesian traditional fermented milk dadih might be considered as potential probiotic strains after further characterization with animal models, especially for their therapeutic properties. Five dadih lactic bacteria isolates each had moderate survival rate for 2 h at pH 2.0, as well as bile tolerance. The aim of this research was to identify candidate probiotic lactic bacteria among indigenous dadih lactic isolates originated from Bukit Tinggi, West Sumatra, especially their in vivo antimutagenic property. Milk cultured with Enterococcus faecium IS-27526 significantly lowered fecal mutagenicity of rats as compared to the control group, skim milk, and milk cultured with L. plantarum IS-20506. These results suggest that Enterococcus faecium IS-27526 may serve as a potential probiotic strain with its antimutagenicity.

• Journal of Dairy Science and Biotechnology
• /
• 제25권2호
• /
• pp.5-10
• /
• 2007

Ultrasonication was employed to prepare solid lipid nanoparticles (SLN) for smart probiotic nanoparticles as a nanofood. The model probiotic material, lactocin from Lactobacillus plantarum (CBT-LP2), was incorporated into SLN. The CBT-LP2 loaded SLN (CBT-LP2-SLN) were spherical in the photograph of scanning electron microscope (SEM). The particle size measured by laser diffraction (LD) was found to be $97.3{\pm}8.2nm$. Zeta potential analyzer suggested the zeta potential of LP-SLN was $-29.36{\pm}3.68$ mV in distilled water. The entrapment efficiency (EE%) was determined with the sephadex gel chromatogram and high-performance liquid chromatogram (HPLC), and up to 90.59% of nanofood was incorporated. Stability evaluation showed relatively long-term stability with only slight particle growth (P>0.05) after storage at room temperature for 4 weeks. Therefore, ultrasonication is demonstrated to be a simple, available and effective method to prepare high quality SLN loaded probiotic material.

• 한국축산식품학회지
• /
• 제39권1호
• /
• pp.73-83
• /
• 2019

The aim of this study was to investigate the effect of glucose oxidase (GOX) immobilized on magnetic chitosan nanoparticles (MCNP) on the viability of probiotic bacteria and the physico-chemical properties of drinking yogurt. Different concentrations (0, 250, and 500 mg/kg) of free and immobilized GOX were used in probiotic drinking yogurt samples. The samples were stored at $4^{\circ}C$ for 21 d. During storage, reduction of the number of probiotic bacteria in the samples with enzyme was lower than the control sample (without enzyme). The sample containing 500 mg/kg immobilized enzyme had the highest number of Bifidobacterium lactis and Lactobacillus acidophilus. The samples containing immobilized enzyme had lower acidity than other samples. Moreover, moderate proteolytic activity and enough contents of flavor compounds were observed in these samples. It can be concluded that use of immobilized GOX is economically more feasible because of improving the viability of probiotic bacteria and the physico-chemical characteristics of drinking yogurt.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권22호
• /
• pp.9909-9913
• /
• 2014

Background: Helicobacter pylori (H. pylori) remains an important cause of gastric cancer and peptic ulcer disease worldwide. Treatment of H. pylori infection is one of the effective ways to prevent gastric cancer. However, standard triple therapy for H. pylori eradication is no longer effective in many countries, including Thailand. This study was designed to evaluate the efficacy of adding bismuth and probiotic to standard triple therapy for H. pylori eradication. Materials and Methods: In this prospective single center study, H. pylori infected gastritis patients were randomized to receive 7- or 14-day standard triple therapy plus bismuth with probiotic or placebo. Treatment regimen consisted of 30 mg lansoprazole twice daily, 1 g amoxicillin twice daily, 1 g clarithromycin MR once daily and 1,048mg bismuth subsalicylate twice daily. Probiotic bacteria composed of Bifidobacterium lactis, Lactobacillus acidophilus and Lactobacillus paracasei. Placebo was conventional drinking yogurt without probiotic. CYP2C19 genotyping and antibiotic susceptibility tests were also done. H pylori eradication was defined as a negative $^{13}C$-urea breath test at least 2 weeks after completion of treatment. Results: One hundred subjects were enrolled (25 each to 7- and 14-day regimens with probiotic or placebo). Antibiotic susceptibility tests showed 36.7% metronidazole and 1.1% clarithromycin resistance. CYP2C19 genotyping revealed 40.8%, 49% and 10.2% were rapid, intermediate and poor metabolizers, respectively. The eradication rates of 7- or 14 regimens with probiotics were 100%. Regarding adverse events, the incidence of bitter taste was significantly lower in the 7- day regimen with the probiotic group compared with 7- day regimen with placebo (40% vs. 64%; p=0.04). Conclusions: The 7-day standard triple therapy plus bismuth and probiotic can provide an excellent cure rate of H. pylori (100%) in areas with low clarithromycin resistance such as Thailand, regardless of CYP2C19 genotype. Adding a probiotic also reduced treatment-related adverse events.